Press Releases

All

August 19, 2020

Rakuten Medical Announces Acquisition of Medlight SA

July 7, 2020

Rakuten Medical closes deal with Merck KGaA, Darmstadt, Germany to receive cetuximab for production of Rakuten Medical’s ASP-1929 antibody-drug conjugate

June 29, 2020

Rakuten Medical Receives Conditional Early Approval Designation from Japanese Health Ministry for its Lead Drug, ASP-1929, to Treat Recurrent Head & Neck Cancer

June 22, 2020

Rakuten Medical Presents Data during AACR Characterizing how Illuminox™ (an Investigational Platform based on Photoimmunotherapy) Induces Cancer Cell Death and Enhances the Immune Response Preclinically

June 4, 2020

Rakuten Medical and MD Anderson Announce Strategic Alliance to Advance Illuminox™ Platform for Cancer Treatments

« Previous 1 … 8 9 10 11 12 … 15 Next »

Year Archive

2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Related Content

About Us

About Us
Letter from Our CEO
Leadership
Location

About

About
Letter from Our CEO
Leadership
Location

Pipeline

Pipeline
Expanded Access Program

Pipeline

Pipeline
Expanded Access Program

News

News
Press Releases
Rakuten Medical Stories
Press Kit

News

News
Press Releases
Rakuten Medical Stories
Press Kit

Contact

Privacy Policy

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We use cookies to enhance user experience and to analyze performance and website traffic. View our Privacy Policy for more details.

Cookie Settings Accept All Cookies

Privacy & Cookies Policy

Privacy Overview

We use cookies to enhance user experience and to analyze performance and website traffic. View our Privacy Policy for more details.
Do not sell my personal information

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages. Keeping this cookie enabled helps us to improve our website.

SAVE & ACCEPT